ラマト・ガン（イスラエル）の医師 — ページ2

Dr. Elad Jacoby is a pioneer of pediatric CAR T–cell therapy in Israel. He heads the Pediatric Cell Therapy Center at Sheba Medical Center. Dr. Jacoby specializes in treating relapsed and high-risk pediatric leukemias and lymphomas. He completed fellowships at Johns Hopkins and the U.S. National Cancer Institute.

• Medical Director of the Advanced Biotherapy Center at Sheba Medical Center.
• Authored over 240 scientific publications in pediatric hemato-oncology.
• Board-certified in both Pediatrics and Pediatric Hematology and Oncology.
• Leads the integration of CAR T–cell therapy with bone marrow transplantation.

Dr. Yaacov Lawrence is the Chair of Radiation Oncology at Sheba Medical Center. He specializes in precision radiation therapy and neuro-oncology. Dr. Lawrence pioneered celiac plexus radiosurgery for pancreatic cancer pain management. He holds the FASTRO designation, one of the highest honors in his specialty.

• Leads the Gastrointestinal Cancer Program at Sheba Medical Center.
• Performs stereotactic radiosurgery for brain tumors and nervous system cancers.
• Authored over 280 scientific publications on personalized radiation protocols.
• Completed radiation oncology fellowship training at Thomas Jefferson University.

Dr. Pnina Langevich leads the National Center for Rheumatology at Sheba Medical Center. She is a former Vice President of the World Association of Rheumatologists. Forbes Israel has repeatedly named her among the country’s top doctors. Dr. Langevich treats severe cases of lupus, scleroderma, and rheumatoid arthritis.

• Served for 12 years as Vice President of the World Association of Rheumatologists.
• Functions as the Editor–in–Chief of the international medical journal Lupus.
• Specializes in managing treatment–resistant autoimmune and joint diseases.
• Works at Sheba Medical Center, ranked 7th worldwide by Newsweek in 2026.

Dr. Anton Wohl is the Director of the Brain Tumors Unit at Sheba Medical Center. He specializes in neuro-oncology and complex brain tumor surgery. He completed fellowships at the Mayo Clinic in the USA. Dr. Wohl works at a hospital ranked 7th globally by Newsweek in 2026. He focuses on removing tumors while preserving neurological function.

• Performs awake craniotomy and fluorescence-guided surgery to protect brain function.
• Uses intraoperative MRI and functional brain mapping during complex procedures.
• Author of multiple peer-reviewed studies on glioblastoma and innovative therapies.
• Holds Israeli board certification and an active medical license.

Dr. Beni Boursi is a leading oncologist at Sheba Medical Center. He founded the ECOG-ACRIN Microbiome Working Group. He specializes in treating gastrointestinal cancers using innovative microbial modulation. Dr. Boursi is board certified in internal medicine and medical oncology. He earned his medical degree with highest honors from Tel Aviv University.

• Completed oncology fellowships at the University of Pennsylvania.
• Trained in medical oncology at MD Anderson and Mayo Clinic.
• Developed predictive models for early colorectal and pancreatic cancer diagnosis.
• Published research on microbiome-oncology in the prestigious journal Science.

Prof. Gil Raviv is a specialist in andrology and reconstructive urology at Sheba Medical Center. Forbes named him among the Best Doctors in Israel. He is the director of the Andrology Unit. Dr. Raviv focuses on male infertility, sexual health, and urethral reconstruction. He works at Sheba, a Top 10 world-ranked hospital.

• Performs specialized sperm retrieval techniques including micro-TESE, TESA, and MESA.
• Treats complex conditions like erectile dysfunction, Peyronie’s disease, and azoospermia.
• Uses microsurgical methods and robotic systems for prostate and urological procedures.
• Provides stem cell therapy and shockwave treatment for sexual dysfunction.

Dr. Avichai Shimoni is the Director of Bone Marrow Transplantation at Sheba Medical Center. He treats complex blood cancers. He completed a specialized fellowship at the MD Anderson Cancer Center. Dr. Shimoni uses allogeneic and autologous transplants for high-risk patients. He is a professor and Chairman of Hematology at Tel Aviv University.

• Named among Israel’s Best Doctors by Forbes for 2025 and 2026.
• Authored over 250 scientific papers on cellular therapies and transplantation.
• Provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma.
• Works at Sheba Medical Center, a top-10 hospital globally per Newsweek.

Dr. Hila Magen is a leading Israeli hemato-oncologist at Sheba Medical Center. She heads the Multiple Myeloma and Amyloidosis Unit. Dr. Magen specializes in treating complex plasma cell disorders and high-risk myeloma. She is a principal investigator for innovative point-of-care CAR-T therapy programs. Her work brings advanced immunotherapies into routine clinical care.

• Authored over 100 scientific publications and landmark myeloma studies.
• Completed fellowships at MD Anderson and University of Arkansas for Medical Sciences.
• Performs CAR-T cell therapy and bone marrow transplantations.
• Works at Sheba Medical Center, ranked 7th worldwide in 2026 by Newsweek.

Dr. Roy Mashiach is the Director of Gynecology at Sheba Medical Center in Israel. He specialized in minimally invasive gynecologic surgery and fertility-preserving procedures. Dr. Mashiach received the Daniel F. Kott Award for surgical innovation from the AAGL.

• Serves as the Chairman of the Israeli Society of Gynecological Endoscopy.
• Consistently named among the Best Doctors in Israel by Forbes.
• Specializes in laparoscopic hysterectomy and robot-assisted myoma removal.
• Works at Sheba Medical Center, ranked among the world’s top 10 hospitals.

Dr. Abraham Avigdor is the Director of the Institute of Hematology at Sheba Medical Center. He is a global authority on lymphoma, CAR-T therapy, and complex blood cancers. Dr. Avigdor founded the Israeli Lymphoma Working Group. He helps lead a clinic ranked 7th worldwide by Newsweek in 2026.

• Authored over 130 scientific publications on hemato-oncology and cellular therapy.
• Pioneered the integration of CAR-T cell therapy for lymphoma and myeloma.
• Leads allogeneic and autologous bone marrow transplantation programs.
• Served as the Chairman of the Israeli Lymphoma Study Group.

Dr. Jair Bar is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He specializes in treating advanced non-small cell lung cancer using personalized immunotherapy and targeted treatments. Dr. Bar holds a PhD in Molecular Biology and leads a research lab focused on immunotherapy resistance.

• Chair of the Israel Lung Cancer Group.
• Board-certified in both Medical Oncology and Radiotherapy Oncology.
• Treats patients at Sheba Medical Center, a top-10 globally ranked hospital.
• Uses molecular and genetic profiling to create precise cancer treatment plans.

Dr. Dorit Zilberman is a senior urologist at Sheba Medical Center in Israel. She is a pioneer of robotic and minimally invasive urologic surgery. Dr. Zilberman treats kidney, bladder, and prostate cancers. She helped launch the da Vinci robotic surgery program at Sheba. Forbes Israel recognized her among the nation's best doctors.

• Authored over 160 scientific publications in urologic oncology and endourology.
• Completed fellowship training at Duke University Medical Center in the US.
• Performs robotic prostatectomy, laser lithotripsy, and kidney-sparing surgery.
• Member of the American and European Urological Associations and the Endourological Society.

Dr. Raanan Berger is the Director of the Cancer Center at Sheba Medical Center. He was listed in Forbes Israel’s “Best Doctors” in 2025. Dr. Berger specializes in genitourinary oncology and radiates complex prostate tumors. He completed a postdoctoral fellowship at the Dana-Farber/Harvard Cancer Institute.

• Heads the clinical research unit focusing on molecular oncology.
• Co-authored over 20 peer-reviewed papers on prostate cancer and BRCA mutations.
• Member of the American Society of Clinical Oncology (ASCO).
• Performs systemic therapy and radiotherapy at a Top-10 globally ranked hospital.

Dr. Zohar Dotan heads the Urology Department at Sheba Medical Center in Israel. He is a primary pioneer of robotic and laparoscopic urologic surgery. He specializes in treating complex cancers of the kidney, prostate, and bladder. Dr. Dotan leads the Israeli Uro-Oncology Society and holds a PhD in Genetics.

• Completed a specialized uro-oncology fellowship at Memorial Sloan Kettering in New York.
• Performs robotic radical nephrectomy and da Vinci robotic prostatectomy.
• Authored over 50 scientific publications on advanced urologic cancer treatments.
• Works at Sheba Medical Center, ranked 7th best hospital globally by Newsweek.

Dr. Nir Kleinmann directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is a pioneer in kidney-sparing laser surgery for complex tumors. Forbes and ResultMed named him among Israel’s Best Doctors for 2025 and 2026. Dr. Kleinmann uses a unique dual-laser system to preserve organ function during cancer treatment.

• Completed urological fellowships at Thomas Jefferson University and McMaster University.
• Expert in minimally invasive treatments for UTUC, kidney stones, and prostate cancer.
• Served as a researcher in the OLYMPUS trial for non-surgical chemoablation.
• Fellow of the American Endourology Society with over 60 scientific publications.